Clinical trial
A Prospective, Multi-Center, Open-Label Study to Evaluate the Safety and Tolerability of Hydrogel OA 2% in Patients With Knee Osteoarthritis
NCT07516457 is registered in ClinicalTrials.gov with Allegro NV/SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Center, Open-Label Study to Evaluate the Safety and Tolerability of Hydrogel OA 2% in Patients With Knee Osteoarthritis
- Lead sponsor
- Allegro NV/SA
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 17, 2026
- Completion date
- July 15, 2027
- Enrollment
- 20 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
osteo arthritis of the knee